Untreated obstructive sleep apnea and accelerated cognitive decline over 10 years
People with untreated sleep apnea experienced nearly 70% faster cognitive decline over a decade compared to those using CPAP, highlighting the long-term importance of treatment adherence.
In 777 participants from NHATS 2011–2021 with Medicare-linked OSA diagnoses, untreated OSA was associated with 69% faster cognitive decline over 10 years compared to CPAP-treated peers, addressing the long-standing clinical uncertainty about whether CPAP confers cognitive protection in OSA. The 10-year follow-up substantially extends prior short-term studies that showed limited cognitive benefit, suggesting that long-term CPAP adherence—not short-term trials—is required to see protective effects.
What the study was
- Study design
- longitudinal_cohort_10year
- Category
- aging_longevity_population
- Maturity
- Validated
- Journal
- Alzheimer's & Dementia
Why it surfaced
10-year longitudinal data resolves a key clinical debate about CPAP and cognition in older adults with OSA; directly relevant to dementia prevention policy. Score 6 (N=2, D=2, P=1, E=1) for long-term real-world claims-linked design.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.